TE
IONS icon

Tema ETFs’s Ionis Pharmaceuticals IONS Stock Holding History

Tema ETFs’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$438K Sell
5,525
-148
-3% -$11.1K 0.01% 432
2026
Q1 		$426K Sell
5,673
-2,884
-34% -$228K 0.03% 396
2025
Q4 		$677K Sell
8,557
-3,749
-30% -$282K 0.05% 302
2025
Q3 		$805K Sell
12,306
-15,855
-56% -$774K 0.07% 293
2025
Q2 		$1.11M Buy
28,161
+3,020
+12% +$98.8K 0.3% 104
2025
Q1 		$759K Sell
25,141
-31,703
-56% -$1.04M 0.23% 98
2024
Q4 		$1.99M Buy
+56,844
New +$2.12M 0.83% 37

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Tema ETFs's IONS Position: Q2 2026 in Review

Tema ETFs reduced its Ionis Pharmaceuticals (IONS) stake by 2.6% in Q2 2026, selling an estimated $11.1K and leaving 5,525 shares worth $438K. The position accounts for 0.01% of the portfolio, ranked #432.

Tema ETFs first reported a position in IONS in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.99M in Q4 2024. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Tema ETFs held 5,525 shares of Ionis Pharmaceuticals worth $438K as of Q2 2026.
  • Tema ETFs sold 148 Ionis Pharmaceuticals shares in Q2 2026, an estimated $11.1K.
  • Ionis Pharmaceuticals made up 0.01% of Tema ETFs's portfolio in Q2 2026, its #432 holding.
  • Tema ETFs first reported a position in Ionis Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Tema ETFs's Ionis Pharmaceuticals position peaked at $1.99M in Q4 2024.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.